Utah Medical Products (UTMD) Net Equity Issued and Repurchased (2010 - 2024)
Utah Medical Products' (UTMD) quarterly Net Equity Issued and Repurchased came in at $294000.0 in Q2 2024, up 390.0% year-on-year from $60000.0 in Q3 2023, and up 206.25% quarter-over-quarter from $96000.0 in Q1 2024.
Utah Medical Products (UTMD) Net Equity Issued and Repurchased (2010 - 2024) Analysis & Trends
Utah Medical Products' Net Equity Issued and Repurchased history runs 15 years deep, the most recent figure standing at $294000.0 for Q2 2024.
- On a quarterly basis, Net Equity Issued and Repurchased rose 390.0% year-over-year to $294000.0 in Q2 2024; TTM through Mar 2025 was $294000.0, a 53.12% increase from a year earlier, with the FY2024 full-year figure at $390000.0, up 233.33% from the prior year.
- Net Equity Issued and Repurchased grew to $294000.0 in Q2 2024 per UTMD's latest filing, from $96000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $294000.0 in Q2 2024 and bottomed at $3000.0 in Q2 2021.
- The 5-year median for Net Equity Issued and Repurchased is $60000.0 (2023), against an average of $94058.8.
- Across the five-year window, Net Equity Issued and Repurchased tumbled 90.32% in 2021 and jumped 1400.0% in 2023, its largest moves.
- Year by year, Net Equity Issued and Repurchased stood at $76000.0 in 2020, then soared by 267.11% to $279000.0 in 2021, then tumbled by 53.05% to $131000.0 in 2022, then sank by 72.52% to $36000.0 in 2023, then soared by 716.67% to $294000.0 in 2024.
- Per Business Quant, the three latest UTMD Net Equity Issued and Repurchased figures stand at $294000.0 (Q2 2024), $96000.0 (Q1 2024), and $36000.0 (Q3 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 7.43 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 11.72 Mn |
| 10 | Utah Medical Products | 204.41 Mn | 117.01 Mn | 5.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 294,000.00 |
| Jun 30, 2024 | 294,000.00 |
| Mar 31, 2024 | 96,000.00 |
| Mar 31, 2024 | 96,000.00 |
| Sep 30, 2023 | 36,000.00 |
| Sep 30, 2023 | 36,000.00 |
| Jun 30, 2023 | 60,000.00 |
| Jun 30, 2023 | 60,000.00 |
| Mar 31, 2023 | 21,000.00 |
| Mar 31, 2023 | 21,000.00 |
| Dec 31, 2022 | 131,000.00 |
| Dec 31, 2022 | 131,000.00 |
| Sep 30, 2022 | 20,000.00 |
| Sep 30, 2022 | 20,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 19,000.00 |
| Mar 31, 2022 | 19,000.00 |
| Dec 31, 2021 | 279,000.00 |
| Dec 31, 2021 | 279,000.00 |